Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 14 (11) , 101203
Abstract
No abstract availableKeywords
Funding Information
- CancerCare Manitoba Foundation
- University of Manitoba
- University of Manitoba College of Medicine
This publication has 39 references indexed in Scilit:
- Structure Activity Relationships of N-linked and Diglycosylated Glucosamine-Based Antitumor GlycerolipidsMolecules, 2013
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological featuresVirchows Archiv, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian CancerPLOS ONE, 2010
- Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapyCell Cycle, 2009
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade CarcinomasCancer Research, 2009
- A glycosylated antitumor ether lipid kills cells via paraptosis-like cell deathBiochemistry and Cell Biology, 2009
- Maintenance Treatment with Bevacizumab Prolongs Survival in anIn vivoOvarian Cancer ModelClinical Cancer Research, 2008
- Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patientsNature Protocols, 2006
- Convergent C-Glycolipid Synthesis via the Ramberg−Bäcklund Reaction: Active Antiproliferative GlycolipidsOrganic Letters, 1999